Market Overview

UPDATE: Credit Suisse Raises PT to $41 on HCA Holdings on Positive Reform Exposure

Related HCA
Morgan Stanley Says Ebola Scare Could Defer Elective Surgeries In Texas
3 Hospital Stocks to Buy Now

Credit Suisse maintained HCA Holdings (NYSE: HCA) with a Market Perform rating and raised the price target from $30.00 to $39.00.

Credit Suisse noted, "HCA reported 4Q12 EPS of $0.91, well ahead of consensus of $0.82 and ahead of our $0.89 estimate, driven by strong organic volume growth. The company also issued 2013 guidance that fell below consensus, which was not overly surprising. However, shares traded off early highs as mgmt provided somewhat reserved commentary around healthcare reform, pointing to many uncertainties that still exist, and the likelihood of a multi-yr ramp. We continue to believe reform will be a meaningful positive in 2014 and the 4Q results reinforce the strong market position and execution by HCA."

HCA Holdings closed at $37.51 on Tuesday.

Latest Ratings for HCA

DateFirmActionFromTo
Oct 2014CitigroupMaintainsBuy
Oct 2014BarclaysMaintainsOverweight
Oct 2014Credit SuisseMaintainsOutperform

View More Analyst Ratings for HCA
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Price Target Analyst Ratings

 

Related Articles (HCA)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional